Pelgifatamab (BAY-2315497) is a prostate-specific membrane antigen (PSMA) antibody with potential anticancer activity that can be used to study prostate cancer.
Purity:
97.90%
CAS Number:
[2414550-93-7]
Target:
PSMA
* VAT and and shipping costs not included. Errors and price changes excepted